GlassScriptPhysician profile
Burton Elrod
NPI 1053820514
$1,243.16
in general payments reported to CMS, 2019-2025
10 companies · $550 in 2025
The $550 reported for 2025 was more than what 82% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $164 · 2022: $94.37 · 2023: $162 · 2024: $273 · 2025: $550.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $985.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $984.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $352.62 | 2024-2025 | Evenity, Prolia |
| Cerapedics INC. | $206.33 | 2025 | I-Factor Peptide Enhanced Bone Graft |
| Smith+Nephew, INC. | $163.83 | 2021 | |
| Gilead Sciences, INC. | $114.83 | 2023-2024 | Veklury |
| Djo, LLC | $107.98 | 2025 | Cmf |
| Horizon Therapeutics Plc | $94.37 | 2022 | |
| Medtronic, INC. | $74.82 | 2023 | Cd Horizon Spinal System, Anteralign Spinal System With Titan Nanolock Surface Technology |
| Abbvie INC. | $59.42 | 2024 | |
| Bioventus LLC | $40.37 | 2023 | Bonescalpel |
| Vericel Corporation | $28.59 | 2024 | Maci |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Burton Elrod listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.